Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

---

Ozbalak M., Akay O. M., PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N., ...More

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.21, 2021 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 21
• Publication Date: 2021
• Journal Name: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
• Keywords: relapsed and refractory, Hodgkin lymphoma, brentuximab vedotin, autologous stem cell transplantation, consolidation
• Erciyes University Affiliated: Yes